Royalty Pharma
RPRX
RPRX
318 hedge funds and large institutions have $12.1B invested in Royalty Pharma in 2022 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 126 increasing their positions, 88 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
318
Holders Change
+36
Holders Change %
+12.77%
% of All Funds
5.5%
Holding in Top 10
8
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-20%
% of All Funds
0.14%
New
55
Increased
126
Reduced
88
Closed
19
Calls
$77.9M
Puts
$15.1M
Net Calls
+$62.8M
Net Calls Change
-$7.49M
